This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. Now, patients can expect to see products typical of compounding pharmacies, like capsules, topicals, lozenges, lollipops, and suppositories, with an allowance of up to 10 milligrams of THC each.
We’ve written extensively on this blog about industrial hemp-derived CBD products, including CBD comestibles , CBD pet products , CBD in alcohol , and CBD topicals. Our main priority was safety, effectiveness. As we’ve analyzed before, cosmetics are treated differently under federal law than food products.
Winter Edition 2019 – Cannabis. 2019 Legislative Session – Agency Proposed Legislation. On January 9, 2019 the Board approved a motion to make the effective date for all marijuana product, packaging and labeling requirements Jan 1, 2020. The 2019 legislative session began January 14 and runs through April 28, 2019.
” That distinction is evident is national polls, which show greater public support for medicalization (93 percent: Quinnipiac, 2019 ) over adult-use legalization (66 percent: Gallup, 2019 ). ” Full text of the study, “Has the ‘M’ word been framed?
Hemp CBD topicals represent a significant percentage of the booming CBD market. According to an August 2019 report released by Grand View Research, Inc., Add to that the issue of adulteration and the sad reality that many CBD topicals–and CBD products, generally –contain dangerous substances.
The July 23, 2019 hearing will include Senators Jeff Merkley (D-OR) and the legislation’s chief GOP cosponsor, Cory Gardner (R-CO). Supporters of the Act have stressed the public-safety concerns that have resulted from the lucrative cannabis industry conducting business on a cash-only basis. It’s an $8.3
Authorized persons will be able to create and commercialize a wide variety of products falling within these new categories by October 17, 2019. The amended regulation will establish new control measures to address the public health and safety risks associated with these new categories. Amendment of the Cannabis Regulations.
These methods may include: regular consumption inhalation oral administration local treatment via topical products. In 2019, a small study tested CBD ointment for its therapeutic potential within the skin, including patients with acne, dermatitis, and psoriasis. Is there a difference between topicals and other delivery methods?
The Working Group’s report represents some of the best responsible cannabis policy examining the needs of the community from a variety of aspects including public health and safety as well as social and economic impacts. The impact of LA County’s Supervisors leadership on this topic is immeasurable.
Consultation: Strict regulation of edible cannabis, extracts and topicals. It will close on February 20, 2019. We are seeking feedback on draft regulations to minimize the public health and public safety risks posed by: edible cannabis. cannabis topicals. From: Health Canada. This consultation opened on December 20, 2018.
A study published in Journal of Affective Disorders in 2019 suggested that CBD might help reduce PTSD symptoms. Continued research will help clarify the efficacy and safety of cannabis for PTSD. Even though there is still plenty to learn about how marijuana can help PTSD, there’s no shortage of studies supporting its potential.
Chakraborty requested the PM to type a high-power fee to analysis the topic and inform the federal government about the advantages of hashish as a medicinal plant and as uncooked materials in industrial purposes. “I In 2019, the Border Safety Forces (BSF) intercepted Rs 4.86 crore value of hashish and Rs. Read full article at.
Published: Mar 07, 2019. The California Department of Public Health (CDPH) regulations for cannabis, approved and adopted on January 16, 2019, clarified and updated the packaging and labeling requirements for all cannabis and cannabis products sold within California ( §40400-40417 ). About the Manufactured Cannabis Safety Branch.
In 2019, the list of qualifying conditions was expanded to also include all epileptic disorders, multiple sclerosis, and spasticity, as well as autism, terminal cancer, incurable neurodegenerative diseases, and amyotrophic lateral sclerosis (ALS). THC under the Texas Compassionate Use Ac t. Shutterstock). How to get a medical card in Texas.
We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.
20, 2019 (GLOBE NEWSWIRE) — NEWAGE (NASDAQ: NBEV ) , the Colorado-based healthy products company, announced the launch of its hemp portfolio in Australia and New Zealand. KEY HIGHLIGHTS: NewAge launches its ‘NHANCED Hemp Topical Products in Australia and New Zealand. NHANCED Hemp Topical Products. Attachments.
In March of 2019, the FDA established a Working Group to determine the possible legislative pathways to regulate CBD. On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety.
This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.
The most notable measure that has moved forward in addressing this issue is the above-mentioned SAFE Banking Act, which has been in circulation in Congress since 2019 when U.S. In September 2019, the House of Representatives passed the bill. It does, however, provide a safety net for businesses in the commonwealth that choose to.
Marketing company Distinctive Assets has been gifting the Oscar’s swag for the past 17 years and company founder, Lash Fary, told MarketWatch their 2019 gifts are “directly tied to the broad legalization of cannabis in California last year.”. of the Health & Safety Code. s first cannabis-friendly social club.
In a 2019 animal study, CBN isolate was reported to relieve musculoskeletal pain. One trial has already made it to Phase II and is actively recruiting, meaning that it passed safety and tolerability studies in healthy patients, and trials in specific individuals are already underway. Common cannabinoids in cannabis.
June 14, 2019. Health Canada has released the amendments to the Cannabis Regulations to control the legal production and sale of edible cannabis, cannabis extracts, and cannabis topicals. Prohibiting the production of food and cannabis in the same facility to ensure the safety and integrity of Canada’s food system.
“We need regulation, we need to make sure we’re protecting public health, public safety. November 4, 2019. We need regulation, we need to make sure we’re protecting public health, public safety. This is a very important topic,” Governor Cuomo explained. “It But that’s regulation, not prohibition,” Governor Wolf said.
While patients won’t be rolling up joints full of pungent flower, they can still access oils, tinctures, lozenges, inhalers, topicals, and pills packed with non-intoxicating CBD or THC-A, the acidic precursor of THC.
on a dry weight basis and that is grown or possessed by a licensed grower in compliance with this chapter” and “ includes agricultural commodities and products derived from hemp and topical or ingestible consumer products, including food, food additives and food products derived from hemp.” 459 in March 27, 2019. Emphasis added).
The city of Denver, Colorado, decriminalized the possession and use of psilocybin in 2019—the first U.S. According to The Denver Post , Melanie Rose Rodgers—a prominent activist who helped get psilocybin decriminalized in Denver in 2019—has cited concerns about a corporate takeover of natural medicine following the enactment of Initiative 58.
The scandal surrounding CannTrust’s non-compliance due to five unlicensed grow rooms has been a topic of interest for the past few days. We are currently working on a facility review with Health Canada and as a precaution, we have implemented a voluntary hold on the sale of our medical products as of July 10 th , 2019.”.
In April 2019, Bristol-Myers Squibb acquired Celgene for $74 billion. The European Medicines Agency (EMA) is the regulatory body that evaluates and supervises the production and sales of medicines for safety and benefit of the customer, in the European Union Region. Key Topics Covered: 1. Executive Summary.
The FDA is however finally allowing the public to weigh in, with the announcement of a Public Hearing to take place on May 31, 2019. What’s more, is that the Agency is allowing submission of public comment until July 2, 2019 and seems to earnestly want feedback from the hemp industry. April 20, 2019.
This “zero recall” standard, the team said, was attributed to the fact that their cannabis product standards with regard to food safety and health was high and involved documentation of over 100 pages. . These are the responsibility of the manufacturer. Setting Standards for Cannabis Research Studies . Originally published By: [link].
Google announced in May, 2019 that they had updated their policy section of the Google to ban apps “that facilitate the sale of marijuana or maijruan products, regardless of legality.” And arguably, while most cannabis users know when their stash is running low, there is also a safety matter at play here. Learn More.
1 deadline to train managers and employees under a new compliance and safety program that is the first of its kind in the nation. The state’s Responsible Vendor Training Program is designed to support licensee compliance and enhance the safety of customers and employees. We trained over 1,000 people between Oct. 16 and Dec.
There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Non-clinical research can help answer questions regarding safety and risk in very powerful ways.
We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. Core Business organic growth was 16% in H1 2021 vs. H1 2019, and close to 13% vs. H1 2019 corrected for the EUR 62m estimated missing revenues from the cyber-attack of 2 June 2019. for the three historic TIC leaders.
FDA’s announcement comes on the heels of an active 2019, during which both FDA and the FTC issued warning letters to marketers of CBD products 1 and the plaintiffs’ bar began to actively file class-action lawsuits against marketers of CBD products under state law. The CBD Report discusses FDA initiatives already underway (e.g.,
In a series of posts, we’re going to cover the highlights of each agency’s permanent rules so that you know what big changes to expect during 2019. ” Clearly, safety and federal compliance in the workplace still applies, even to cannabis operators, which is now demoralized under the permanent MCSB rules.
Can-Lab offers rapid turn-around times to deliver results across ten analytic “panels” that test and certify the purity and potency of cannabis flower , edibles , concentrates , and topicals. Can-Lab is an ISO-certified, licensed State of Michigan Safety Compliance Facility and Michigan’s leading cannabis lab and analytic provider.
This statewide change follows New York City ’s April 2019 ban on pre-employment cannabis testing, which deems screening for marijuana or THC as a condition of employment to be an unlawful discriminatory practice, with limited exceptions.
Sales appear to have peaked in 2019, when natural channel consumers spent more than $90.7 Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. million on these products.
However THCP, an intoxicating cannabinoid discovered in 2019, is too novel to fully establish its legal status. Key Topics Covered: Executive summary. Safety concerns. The publisher believes that many products made from hemp-derived cannabinoids, such as THC isomers and HHC, do not violate federal controlled substance law.
A judge in the Travis County District Court in Texas ruled that a ban on smokable hemp in the state is unconstitutional—siding with several hemp companies that filed a lawsuit , challenging the 2019 ban on smokable hemp products passed by Texas lawmakers.
“One of the main reasons I’m here today is, we filed a new lawsuit against the OMMA, against Director Williams, against her secretary, against a lot of the new members of the board of health and the food safety standard board,” Durbin said. Approximately 100 people attended the rally, according to Fox 25. “We
Prior to opening her own firm, she was appointed as Senior Policy Advisor at the Bureau of Medical Cannabis Regulation, where she developed regulations and negotiated with stakeholders regarding the implementation of the Medical Cannabis Regulation and Safety Act (MCRSA).
per cent over the 2019 – 2027 period. The information came alongside the firm’s release of a for-purchase report on the topic. December 17, 2019 11:43 AM Eastern Standard Time. million in 2019, and is expected to exhibit a CAGR of 15.7% over the forecast period (2019 – 2027). Research Institutes. Pennsylvania.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content